In SSc, higher serum CCL20 levels correlated with clinical parameters of PAH [24], and an increase in CCL20 expression paralleled by a decrease in CCR6 was reported in dermal SSc fibroblasts and MVECs, respectively [25]. The gene discussed is CCL20; the disease is pulmonary arterial hypertension.